Skip to main content

Paulson Richard A.

In the past year, 2 open-market sale filings worth $137.2K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$137.2K
2 filings
Net
−$137.2K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Paulson Richard A. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

KPTI Karyopharm Therapeutics Inc.

President and CEO42 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 5, 2022 (view filing)May 41 dayPaulson Richard A.President and CEOSSale−28.5K$6.23−$177.6K−4.3%633.4K after2 lots
Jun 8, 2022 (view filing)Jun 71 dayPaulson Richard A.President and CEOSSale−2.54K$5.76−$14.6K−0.4%630.9K after
Jul 11, 2022 (view filing)Jul 83 daysPaulson Richard A.President and CEOSSale−2.12K$5.18−$11.0K−0.3%628.8K after
Aug 5, 2022 (view filing)Aug 41 dayPaulson Richard A.President and CEOSSale−2.31K$4.48−$10.4K−0.4%626.5K after
Sep 9, 2022 (view filing)Sep 81 dayPaulson Richard A.President and CEOSSale−3.48K$5.23−$18.2K−0.6%623.0K after2 lots
Oct 5, 2022 (view filing)Oct 41 dayPaulson Richard A.President and CEOSSale−3.49K$5.87−$20.5K−0.6%619.5K after
Nov 8, 2022 (view filing)Nov 44 daysPaulson Richard A.President and CEOSSale−3.49K$4.54−$15.9K−0.6%616.0K after
Dec 6, 2022 (view filing)Dec 51 dayPaulson Richard A.President and CEOSSale−3.49K$5.17−$18.0K−0.6%612.5K after
Jan 5, 2023 (view filing)Jan 41 dayPaulson Richard A.President and CEOSSale−3.92K$3.27−$12.8K−0.6%608.6K after
Feb 8, 2023 (view filing)Feb 62 daysPaulson Richard A.President and CEOSSale−3.95K$3.40−$13.4K−0.6%604.7K after

See all 42 trades at KPTI